Urodynamix Technologies Ltd.

	Sign up to receive news releases and updates by email:

	Subscribe
	Unsubscribe

2006

November 2	Urodynamix Announces Appointment of New Director and Issuance of Stock Options
October 4	Urodynamix Begins Enrollment for NIRS Study of Urinary Incontinence in Women
September 26	Urodynamix Initiates US Clinical Study of NIRS Technology
September 13	Urodynamix Announces Management Change
July 31	Urodynamix Reports Successful Results for NIRS in Stress Urinary Incontinence and Over Active Bladder in Women
July 26	Urodynamix Successfully Raises $2,419,325
July 5	Urodynamix reports successful results of NIRS in Prostate Study
June 30	Urodynamix receives TSX Venture approval for warrant incentive program
June 21	MDX Changes Company Name to Urodynamix Technologies Ltd. to Reflect New Focus on Urology Products and Trading Symbol to URO Effective June 21, 2006
June 9	MDX AGM Summary MDX to Change Company Name to Urodynamix Technologies Ltd. and Trading Symbol to URO
May 23	MDX Completes Patient Enrollment for CIHR Study of NIRS Technology
May 17	MDX Licenses AVID Technology to Japanese Company
April 10	MDX to Develop a Non-Invasive Urodynamics Device
February 22	MDX Begins NIRS Urodynamics Clinical Study
February 15	MDX Medical Hires VP Marketing & Communication